ALL risk stratification gene panel covers the following: (Hotspot genes: ABL1, FLT3, JAK2, KRAS, NRAS; Full genes: ETV6, IKZF1, TP53 Gene fusions: CREBBP, JAK2, KMT2A, ETV6, TCF3. It is a comprehensive genetic test used to detect and identify specific genetic alterations associated with B-Acute Lymphoblastic Leukemia. It utilizes next-generation sequencing (NGS) technology to simultaneously analyze multiple genes known to be implicated in these malignancies. The panel provides valuable information about gene mutations, gene fusions, and other genetic alterations that can aid in diagnosis, prognosis, and treatment decisions. The test allows for a more targeted and personalized approach to managing B-ALL.
Contains3 tests
Earliest reports in18 days
Samples requiredBlood
ForMen & women
What does ALL Risk Stratification Gene Panel- B - ALL measure?
Package contains 3 tests
Hotspot Genes: ABL1, FLT3, JAK2, KRAS, NRAS
Full Genes: ETV6, IKZF1,TP53
Gene Fusions : CREBBP, JAK2, KMT2A, ETV6, TCF3
Samples required
BloodOur phlebotomist will draw a blood sample, typically from a vein in your inner elbow.